Spots Global Cancer Trial Database for Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Official Title: A Phase 1b, Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Sotorasib Monotherapy and in Combination With Other Anti-cancer Therapies in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Study ID: NCT04185883
Study Description
Brief Summary: To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Arizona Oncology Associates Professional Corporation, Tucson, Arizona, United States
City of Hope National Medical Center, Duarte, California, United States
University of California San Diego Moores Cancer Center, La Jolla, California, United States
Loma Linda University Cancer Center, Loma Linda, California, United States
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California, United States
University of California Davis Medical Center, Sacramento, California, United States
University of California at SF, San Francisco, California, United States
University of California Los Angeles, Santa Monica, California, United States
Rocky Mountain Cancer Centers Denver Midtown, Denver, Colorado, United States
Sarah Cannon Research Institute at HealthONE, Denver, Colorado, United States
Yale Cancer Center, New Haven, Connecticut, United States
Norwalk Hospital, Norwalk, Connecticut, United States
Memorial Cancer Institute, Pembroke Pines, Florida, United States
Moffitt Cancer Center, Tampa, Florida, United States
Emory University, Atlanta, Georgia, United States
Northwestern University, Chicago, Illinois, United States
University of Chicago Medical Center, Chicago, Illinois, United States
Indiana University, Indianapolis, Indiana, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
University of Michigan, Ann Arbor, Michigan, United States
Henry Ford Health System, Detroit, Michigan, United States
Washington University, Saint Louis, Missouri, United States
Montefiore Medical Center, Bronx, New York, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Columbia University Medical Center, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Levine Cancer Institute, Charlotte, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
University of Cincinnati Medical Center, Cincinnati, Ohio, United States
Cleveland Clinic, Cleveland, Ohio, United States
Providence Portland Medical Center, Portland, Oregon, United States
Oregon Health and Science University, Portland, Oregon, United States
Thomas Jefferson University, Philadelphia, Pennsylvania, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
University of Pennsylvania, Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center Cancer Pavillion, Pittsburgh, Pennsylvania, United States
Gibbs Cancer Center and Research Institute - Spartanburg, Spartanburg, South Carolina, United States
Avera Cancer Institute, Sioux Falls, South Dakota, United States
Henry Joyce Cancer Center, Nashville, Tennessee, United States
Texas Oncology - Austin Midtown, Austin, Texas, United States
Mary Crowley Cancer Research, Dallas, Texas, United States
University of Texas Southwestern Medical Center, Dallas, Texas, United States
Oncology Consultants, Houston, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
United States Oncology Regulatory Affairs Corporate Office, The Woodlands, Texas, United States
US Oncology Research Investigational Products Center, The Woodlands, Texas, United States
Texas Oncology Northeast Texas, Tyler, Texas, United States
Huntsman Cancer Institute, Salt Lake City, Utah, United States
University of Virginia, Charlottesville, Virginia, United States
Virginia Cancer Specialists, PC, Fairfax, Virginia, United States
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Northwest Medical Specialties, PLLC, Tacoma, Washington, United States
Northwest Cancer Specialists - Vancouver, Vancouver, Washington, United States
Nepean Cancer Centre, Kingswood, New South Wales, Australia
GenesisCare -North Shore Oncology, St Leonards, New South Wales, Australia
Icon Cancer Care South Brisbane, South Brisbane, Queensland, Australia
The Queen Elizabeth Hospital, Woodville South, South Australia, Australia
St John of God Healthcare, Subiaco, Western Australia, Australia
Medizinische Universitaet Graz, Graz, , Austria
Landeskrankenhaus Salzburg, Salzburg, , Austria
Universite Catholique de Louvain Cliniques Universitaires Saint Luc, Bruxelles, , Belgium
Universitair Ziekenhuis Antwerpen, Edegem, , Belgium
CHU de Quebec Hopital de l Enfant Jesus, Quebec, , Canada
Charite Universitaetsmedizin Berlin, Campus Virchow, Berlin, , Germany
Universitaetsklinikum Dresden, Dresden, , Germany
Universitaetsklinikum Essen, Essen, , Germany
Universitatsklinikum Koln, Koeln, , Germany
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milano, , Italy
Azienda Ospedaliero Universitaria Pisana, Pisa, , Italy
Centro Ricerche Cliniche Di Verona Societa responsabilita limitata, Verona, , Italy
Aichi Cancer Center, Nagoya-shi, Aichi, Japan
National Cancer Center Hospital East, Kashiwa-shi, Chiba, Japan
The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan
Seoul National University Hospital, Seoul, , Korea, Republic of
The Catholic University of Korea Seoul St Marys Hospital, Seoul, , Korea, Republic of
Asan Medical Center, Seoul, , Korea, Republic of
Universitair Medisch Centrum Utrecht, Utrecht, , Netherlands
Hospital Universitari Vall d Hebron, Barcelona, Cataluña, Spain
Hospital Clinic i Provincial de Barcelona, Barcelona, Cataluña, Spain
Institut Catala d Oncologia Hospitalet Hospital Duran i Reynals, Hospitalet de Llobregat, Cataluña, Spain
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain
Hospital Universitario Ramon y Cajal, Madrid, , Spain
Hospital Universitario 12 de Octubre, Madrid, , Spain
National Cheng Kung University Hospital, Tainan, , Taiwan
National Taiwan University Hospital, Taipei, , Taiwan
Taipei Veterans General Hospital, Taipei, , Taiwan
Linkou Chang Gung Memorial Hospital of Chang Gung Medical Foundation, Taoyuan, , Taiwan
Sarah Cannon Research Institute UK, London, , United Kingdom
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
